Cite
Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report
MLA
Bénédicte Billi, et al. “Intravenous Immunoglobulins for the Treatment of Prolonged COVID-19 in Immunocompromised Patients: A Brief Report.” Frontiers in Immunology, vol. 15, Apr. 2024. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1399180.
APA
Bénédicte Billi, Paul Cholley, Vincent Grobost, Mélissa Clément, Virginie Rieu, Guillaume Le Guenno, & Hervé Lobbes. (2024). Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1399180
Chicago
Bénédicte Billi, Paul Cholley, Vincent Grobost, Mélissa Clément, Virginie Rieu, Guillaume Le Guenno, and Hervé Lobbes. 2024. “Intravenous Immunoglobulins for the Treatment of Prolonged COVID-19 in Immunocompromised Patients: A Brief Report.” Frontiers in Immunology 15 (April). doi:10.3389/fimmu.2024.1399180.